People who wish to undergo different cosmetic procedures are forced to think twice about their plans because of these procedures’ high possibility of scarring. Going through surgery to sculpt a certain part of the body would be useless if the area will be disfigured by unsightly scars and bruises. Even if the scars brought about by cosmetic surgeries are small and placed in strategic places, wouldn’t it be better if patients can do away with them completely?
Other than eating types of food that are known to give benefits to the skin, people cannot really do anything else to save their skin from the unsightly effects of open wounds. Different brands of creams and serums may be used to speed up the recovery process but they do not have the ability to lighten or to remove visible scars. Most scar reduction measures are only implemented after the scars have been incurred. But most of the time, they fail to yield results that people usually expect from them.
Fortunately, a group of scientists from the United Kingdom has invented a new medication that will not only shorten the amount of time required for the wounds to heal, but lighten the scar and make the skin feel normal as well. The drug, called Juvista, is a very effective scar reducer that minimizes scars resulting from surgeries and accidents and correct even the most extreme cases of facial blemishes.
Treating scars usually involve a series of bodily processes that makes way for the wounds to heal naturally. When the immune system overreacts in its effort to close the wound, it produces too much skin in an effort to close it. This is the main reason for the appearance of scars. With Juvista, scientists found a way to make closing the wounds faster without driving the immune system to overcompensate.
Juvista may be administered to the wounded area to help the skin tissues heal faster. The sooner that the drug is injected to the skin near the wounds, the better effect it will have it reducing permanent damage. Juvista may also be administered before an operation to ensure that the skin will heal as smoothly as possible. Studies done about the effects of the drug has specifed satisfactory long-term and short-term effects.
The drug uses an ingredient called Transforming Growth Factor B3, which is a protein that can usually be found in embryonic wounds and skin. TGFB3 works using the same principle as healing embryos in minimizing wound effects.
Other scar reduction measures are originally invented for another purpose. For example, silicone gels may be used to treat scars but they are specifically designed for another purpose. Juvista is the only scar reducer that is especially formulated to minimize scarring. Using a high concentration of TGFB3, the cytokine signals that are transferred among molecules are improved and communication of messages between the cells are made to be more efficient.